Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Penk

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Mycoses|January 1, 1997
[High-dose therapy with fluconazole > or = 800 mg/day. Review]A Penk, L Pittrow
Mycoses|December 22, 2017
Role of fluconazole in the long-term suppressive therapy of fungal infections in patients with artificial implantsA Penk, L Pittrow
Mycoses|December 22, 2017
Therapeutic experience with fluconazole in the treatment of fungal infections in diabetic patientsA Penk, L Pittrow
Mycoses|December 22, 2017
Special pharmacokinetics of fluconazole in septic, obese and burn patientsL Pittrow, A Penk
Mycoses|January 1, 1997
Plasma and tissue concentrations of fluconazole and their correlation to breakpointsL Pittrow, A Penk
Mycoses|June 24, 2000
Special pharmacokinetics of fluconazole in septic, obese and burn patientsL Pittrow, A Penk
Mycoses|March 23, 1999
[Status of fluconazole in the therapy of endogenous Candida endophthalmitis]A Penk, L Pittrow
Mycoses|March 23, 1999
[Pharmacokinetics and dosage of fluconazole in continuous hemofiltration (CAVH, CVVH) and hemodialysis (CAVHD, CVVHD)]L Pittrow, A Penk
Mycoses|March 23, 1999
[Fungal arthritis--a rare complication of systemic candidiasis or orthopedic intervention. Review of therapeutic experience with fluconazole]A Penk, L Pittrow
Mycoses|June 24, 2000
Role of fluconazole in the long-term suppressive therapy of fungal infections in patients with artificial implantsA Penk, L Pittrow
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Mycoses|January 1, 1997
[High-dose therapy with fluconazole > or = 800 mg/day. Review]A Penk, L Pittrow
Mycoses|December 22, 2017
Role of fluconazole in the long-term suppressive therapy of fungal infections in patients with artificial implantsA Penk, L Pittrow
Mycoses|December 22, 2017
Therapeutic experience with fluconazole in the treatment of fungal infections in diabetic patientsA Penk, L Pittrow
Mycoses|December 22, 2017
Special pharmacokinetics of fluconazole in septic, obese and burn patientsL Pittrow, A Penk
Mycoses|January 1, 1997
Plasma and tissue concentrations of fluconazole and their correlation to breakpointsL Pittrow, A Penk
Mycoses|June 24, 2000
Special pharmacokinetics of fluconazole in septic, obese and burn patientsL Pittrow, A Penk
Mycoses|March 23, 1999
[Status of fluconazole in the therapy of endogenous Candida endophthalmitis]A Penk, L Pittrow
Mycoses|March 23, 1999
[Pharmacokinetics and dosage of fluconazole in continuous hemofiltration (CAVH, CVVH) and hemodialysis (CAVHD, CVVHD)]L Pittrow, A Penk
Mycoses|March 23, 1999
[Fungal arthritis--a rare complication of systemic candidiasis or orthopedic intervention. Review of therapeutic experience with fluconazole]A Penk, L Pittrow
Mycoses|June 24, 2000
Role of fluconazole in the long-term suppressive therapy of fungal infections in patients with artificial implantsA Penk, L Pittrow
Pageof 2